These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18667930)

  • 1. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
    Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
    Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
    J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
    Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
    Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmasking of PML by HAART: unusual clinical features and the role of IRIS.
    Sidhu N; McCutchan JA
    J Neuroimmunol; 2010 Feb; 219(1-2):100-4. PubMed ID: 19962769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center.
    Lima MA; Silva MTT; Afonso LA; Vaz BJP
    J Neurol Sci; 2017 Oct; 381():321-324. PubMed ID: 28991708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.
    Antinori A; Ammassari A; Giancola ML; Cingolani A; Grisetti S; Murri R; Alba L; Ciancio B; Soldani F; Larussa D; Ippolito G; De Luca A
    J Neurovirol; 2001 Aug; 7(4):323-8. PubMed ID: 11517411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital.
    Riveiro-Barciela M; Falcó V; Burgos J; Curran A; Van den Eynde E; Navarro J; Villar del Saz S; Ocaña I; Ribera E; Crespo M; Pahissa A
    HIV Med; 2013 Jan; 14(1):21-30. PubMed ID: 22726389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.
    Cinque P; Pierotti C; Viganò MG; Bestetti A; Fausti C; Bertelli D; Lazzarin A
    J Neurovirol; 2001 Aug; 7(4):358-63. PubMed ID: 11517417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
    Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
    Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowly progressive fatal PML-IRIS following antiretroviral initiation at CD4+ nadir of 350 cells/mm
    Sandhu MR; Rutledge R; Grant M; Mahajan A; Spudich S
    Int J STD AIDS; 2019 Jul; 30(8):810-813. PubMed ID: 31046614
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?
    Fanjul F; Riveiro-Barciela M; Gonzalez J; Delgado E; Murillas J; Payeras Cifré A; Falcó V; Riera M
    HIV Med; 2013 May; 14(5):321-5. PubMed ID: 23217049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.
    Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.